2013 SABCS Public All Photos

San Antonio, TX -SABCS 2013 San Antonio Breast Cancer Symposium: S Hurvitz addresses General Session 1 about S1-02. Final analysis of a phase II 3-arm randomized trial of neoadjuvant trastuzumab or lapatinib or the combination of trastuzumab and lapatinib, followed by six cycles of docetaxel and carboplatin with trastuzumab and/or lapatinib in patients with HER2+ breast cancer (TRIO-US B07) session at the 2013 San Antonio Breast Cancer Symposium here today, Wednesday December 11, 2013. Over 7500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention.
Photo by © SABCS/Todd Buchanan 2013 Technical Questions: todd@medmeetingimages.com

HurvitzS